期刊文献+

35例复发麻风患者耐药基因检测 被引量:2

Genic testing for drug - resistance in 35 relapsed leprosy patients
下载PDF
导出
摘要 目的:检测麻风菌对氨苯砜(DDS)和利福平(RFP)的耐药。方法:收集临床麻风复发病例皮损组织标本,巢式PCR扩增DDS和RFP耐药基因片段,用直接测序鉴定耐药基因突变。结果:在35例复发病例的皮损组织标本中,共检测出12例DDS耐药基因突变,有5种突变型。但未发现利福平耐药菌株。结论:尽管本研究没有发现利福平耐药菌株,但仍应继续开展对利福平耐药的监测。 Objective: To detect drug resistance in relapsed leprosy patients. Methods: Skin lesions were obtained from relapsed leprosy patients. Dapsone (DDS) and rifampicin (RFP) resistant gene segments were tested by nested PCR, and PCR products were sequenced to identify mutations. Results: DDS resistance was discovered in 12 of 35 re- lapsed leprosy cases with five mutation patterns. No RFP- resistant strain was identified. Conclusion: Monitoring RFP resistance should continue, in spite of the negative result in the current study.
出处 《中国麻风皮肤病杂志》 2011年第1期6-8,共3页 China Journal of Leprosy and Skin Diseases
基金 NIH/DMID 05-0097
关键词 麻风病 复发 耐药基因检测 PCR扩增 leprosy relapse DDS and RFP- resistance nested- PCR
  • 相关文献

参考文献12

  • 1Pettit JHS,Rees RJW.Sulphone resistance in leprosy.An experimental and clinical study.Lancet 1964:673-674.
  • 2Chen Jiakun,Wang Siyu,Hou Yuhong,et al.Primary dapsone resistance in China Lepr Rev 1989;60:263-266.
  • 3Ji BH,Chen JK.Secondary dapsone resistant leprosy in Shanghai municipality.Lepr Rev 1983;54:197-202.
  • 4Shepard CC.Study in mice of the action of DDS against Mycobacterium leprae.Int J Lepr 1967;35(4):616-624.
  • 5Cole ST,Eiglmeier K,Darkhill J,et al.Massive gene decay in the leprosy bacillus.Nature 2001;409(6823):1007-1011.
  • 6Maeda S,Matsuoka M,Nakata N,et al.Multidrug resistant mycobacterium leprae from patients with leprosy.Antimicrobial Agents and Chemotherapy 2001;45(12):3635-3639.
  • 7Williams DL,Pittman TL,Gillis TP,et al.Simultaneous detection of mycobacterum leprae and its susceptibility to dapsone using DNA heteroduplex analysis.J Clin Microbiol 2001;39(6):2083-2088.
  • 8Williams DL,Spring L,Harris E,et al.Dihydropteroate syhthase of mycobacteruim leprae and dapsone resistance.Antimiccrobiol.Agents & Chemothe 2000;44(6):1530-1537.
  • 9Gupta UD,Katoch K,Katoch VM.Study of rifampicin resistance and comparison of dapsone resistance of M.leprae in pre-and post-MDT era.Indian J Lepr 2009;81(3):131-134.
  • 10Matsuoka M.Drug resistance in leprosy.Jpn J Infect Dis 2010;63(1):1-7.

同被引文献29

  • 1翁小满,温艳,王红斌,李桓英.新发和复发麻风患者中麻风菌的氨苯砜、利福平耐药基因的检测[J].中国麻风皮肤病杂志,2005,21(2):89-92. 被引量:3
  • 2温艳,翁小满,李桓英.建立巢式PCR和异源双链法检测石蜡标本麻风菌DDS耐药株[J].中国麻风皮肤病杂志,2005,21(11):847-850. 被引量:5
  • 3王红斌,翁小满,温艳,李桓英.巢式聚合酶链反应检测麻风菌利福平耐药基因的研究[J].中华检验医学杂志,2005,28(10):1015-1017. 被引量:5
  • 4陈贤义,李文忠,陈家琨.麻风防治手册[M].北京:北京科技出版社,2002:2.
  • 5World Health Organization. Global leprosy situations, 2010. Weekly epidemiologieal record, 2010,85 : 337.
  • 6Balagon MF, Cellona RV, Cruz ED, et al. Long- term relapse risk of muhibaeillary leprosy after completion of 2 years of multiple drug therapy (WHO - MDT) in Cebu, Philippines. Am J "Prop Med Hyg, 2009,81 : 895.
  • 7Kaimal S, Thappa DM. Relapse in leprosy. Indian J Lepr, 2009, 75:126.
  • 8Lopez- Roa RI, Fafutis- Morris M, Matsuoka M. A drug- resis- tant leprosy ease detected by DNA sequence analysis from a relapsed Mexican leprosy patient. Rev Lantinoam Microbiol, 2006,48: 256 - 259.
  • 9World Health Organization. Drug resistance in leprosy: reports from selected endemic countries. Weekly Epidemiological Record, 2009, 84:264.
  • 10World Health Organization. Surveillance of drug resistance in lepro- sy: 2009. Weeldy Epidemiologieal Record, 2010,85 : 281.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部